<?xml version="1.0"?>

<document>
	<title>Enzyme studies.  pp.  285-90.</title>

	<author>Nadler-H-L.</author>

	<source>In: Mangos JA, Talamo RC, ed. Cystic fibrosis: projections into the
   future. New York, Stratton, 1976. WI 820 C9995 1976. (REVIEW).</source>

	<abstract>It has been reported that saliva and serum of patients contain
   macromolecular &quot;factors&quot; which are presumably cationic and inhibit
   transport of electrolytes, induce dyskinesis or degranulate
   sensitized polymorphonuclear leukocytes and contain polypeptide
   moieties.  The difference between levels of trypsin-like activity of
   mixed saliva of patients with cystic fibrosis and controls has been
   confirmed.  A number of studies have been carried out in order to
   determine if a deficiency of proteolytic activity might account for
   the presence of cystic fibrosis serum factors.  It was presumed that
   the observed partial deficiency of arginine esterase activity might
   well represent the total deficiency of one of several arginine
   esterases assayed under the experimental conditions.  Although it was
   postulated that the deficiency of arginine esterase activity is
   related to the elevation of the levels of polypeptide or protein
   &quot;factors&quot;, the hydrolysis of peptide bands by activated plasma could
   not be demonstrated, probably due to the limitations of the methods
   employed.  The deficiency of plasma arginine esterase in cystic
   fibrosis has been questioned and confirmed in another laboratory.</abstract>

	<majorsubject>CYSTIC-FIBROSIS: en</majorsubject>
	<majorsubject>ESTERASES: me</majorsubject>
	<majorsubject>PEPTIDE-PEPTIDOHYDROLASES:  me</majorsubject>

	<minorsubject>ARGININE</minorsubject>
	<minorsubject>ESTERASES: df</minorsubject>
	<minorsubject>KALLIKREIN: me</minorsubject>
	<minorsubject>MONOGRAPH</minorsubject>
	<minorsubject>PAROTID-GLAND: en</minorsubject>
	<minorsubject>REVIEW</minorsubject>
	<minorsubject>SALIVA: en</minorsubject>
	<minorsubject>TRYPSIN-INHIBITORS: pd</minorsubject>

	<reference>001   MANGOS JA             SCIENCE                        158   135 967</reference>
	<reference>002   MANGOS JA             PEDIATR RES                      1   436 967</reference>
	<reference>003   SPOCK A               PEDIATR RES                      1   173 967</reference>
	<reference>004   BOWMAN BH             SCIENCE                        164   325 969</reference>
	<reference>005   BOWMAN BH             SCIENCE                        167   871 970</reference>
	<reference>007   DOGGETT RG            TEX REP BIOL MED                31   685 973</reference>
	<reference>008   MANGOS JA             PEDIATR RES                      2   378 968</reference>
	<reference>009   RAO GJS               J PEDIATR                       80   573 972</reference>
	<reference>010   RAO GJS               SCIENCE                        177   610 972</reference>
	<reference>011   SCHONI M              EUR J CLIN INVEST                5   153 975</reference>
	<reference>012   TAYLOR A              PEDIATR RES                      8   861 974</reference>
	<reference>013   RAO GJS               PEDIATR RES                      8   684 974</reference>
	<reference>014   RAO GJS               PEDIATR RES                      9   739 975</reference>
	<reference>015   COLMAN RW             J CLIN INVEST                   48    23 969</reference>
	<reference>016   COLMAN RW             PROG HEMATOL                     7   255 971</reference>
	<reference>017   BARRETT AJ            BIOCHEM J                      131   809 973</reference>
	<reference>018   GLOVER G              J BIOL CHEM                    246  4594 971</reference>
	<reference>019   GROSKOPF WR           J BIOL CHEM                    244   359 969</reference>
	<reference>020   CHASE T JR            BIOCHEMISTRY                     8  2212 969</reference>
	<reference>021   TALAMO RC             PEDIATR RES                      6   430 972</reference>
	<reference>022   LIEBERMAN J           PEDIATR RES                      3   571 969</reference>
	<reference>023   LIEBERMAN J           AM REV RESPIR DIS              109   399 974</reference>
	<reference>024   COBURN MD             AM REV RESPIR DIS              110   368 974</reference>
	<reference>025   CONOVER JH            LIFE SCI                        14   253 974</reference>
	<reference>026   LIEBERMAN J           AM REV RESPIR DIS              111   100 975</reference>

	<citation>1   HALLINAN F            MED HYPOTHESES                   7   793 981</citation>
	<citation>2   DANDONA P             THORAX                          36    60 981</citation>
	<citation>3   WILSON GB             MED HYPOTHESES                   8   527 982</citation>

</document>
